Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies.
Sberro-Soussan R, Zuber J, Suberbielle-Boissel C, Candon S, Martinez F, Snanoudj R, Rabant M, Pallet N, Nochy D, Anglicheau D, Leruez M, Loupy A, Thervet E, Hermine O, Legendre C.
Sberro-Soussan R, et al. Among authors: anglicheau d.
Am J Transplant. 2010 Mar;10(3):681-6. doi: 10.1111/j.1600-6143.2009.02968.x. Epub 2010 Feb 1.
Am J Transplant. 2010.
PMID: 20121729
Free article.